High dose statins in elderly
Web25 de set. de 2014 · High doses or high-potency statins in elderly people may not increase effectiveness, but may increase the risk of adverse effects such as muscle-related aches, pains and weakness. Hence, statin use in the elderly requires frequent review and consideration of their therapeutic goals, quality of life, risk–benefit ratio and life expectancy. Web19 de dez. de 2024 · The MIRACL study looked at the effects of a high dose of Lipitor on 3086 patients in the hospital after angina or nonfatal MI and followed them for 16 weeks. 37 According to the abstract: ... My …
High dose statins in elderly
Did you know?
Webthere seems no controversy in initiation of statins in patients for primary prevention up to 80 years of age. Elderly people are at highest risk of cardiovascular morbidity and mortality, … WebManaging hypercholesterolemia and preventing cardiovascular events in elderly and younger Chinese adults: focus on rosuvastatin Zhen Wang, Junbo GeDepartment of Cardiology, Zhongshan Hospital, Shanghai, People's Republic of ChinaAbstract: Coronary heart disease (CHD) is the leading cause of death worldwide. The efficacy and safety of …
WebStatins are drugs that lower your cholesterol. But if you are age 75 or older and you haven’t had symptoms of heart disease, statins may be a bad idea. Here’s why: Adults age 75 … Web8 de mai. de 2024 · Statins have proved beneficial for the prevention of cardiovascular disease in adults, 1, 2, 3 but patients >75 years have been underrepresented in …
WebThe USPSTF concludes with moderate certainty that initiating use of low- to moderate-dose statins for the prevention of CVD events and mortality in adults aged 40 to 75 years without a history of ... Web25 de set. de 2014 · High doses or high-potency statins in elderly people may not increase effectiveness, but may increase the risk of adverse effects such as muscle …
WebNational Center for Biotechnology Information
Web18 de mai. de 2024 · Given the compelling data supporting statin therapy in the high-risk elderly population, ... Jukema JW, de Craen AJ, Eisenberg MJ. Statins for secondary … dfo reversal of fateWebPurpose: Although moderate- to high-intensity statin therapy is increasingly recommended in cardiovascular disease patients, the efficacy and safety in elderly … churu news liveWeb2 de jan. de 2024 · Recommended statins based on low-density lipoprotein cholesterol (LDL-C) before treatment is 70-189 mg/dl in the age range of 40-75 years in the … dfo right whale closuresWebFor primary prevention of CVD, high-intensity statin treatment (atorvastatin 20 mg daily) should be considered in people (without the need for a formal risk assessment): With … chur university of applied sciencesWebThis risk can be heightened by factors such as high cholesterol, diabetes and high blood pressure, even in those who are otherwise seemingly healthy.” “Previous clinical trials – … churu news todayWeb17 de mar. de 2024 · The dose response and tolerance should be assessed in about 6-8 weeks. If LDL-C reduction is adequate (≥30% reduction with intermediate- and 50% with high-intensity statins), regular interval monitoring of risk factors and compliance with statin therapy are necessary to determine adherence and adequacy of effect (about 1 year). churumuco michoacanWeb2 de out. de 2024 · Statin drugs have been shown to reduce the risk of cardiovascular disease (CVD) in young and middle-aged adults. With older adults (those 75 and over), … chur university